Corporate Ventures Fund of Merck KGaA, Darmstadt, Germany, Creates New Immuno-Oncology Company iOnctura
Darmstadt, Germany, June 20, 2016 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced its corporate venture arm created iOnctura SA, Geneva, Switzerland.